[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitis (FOCUS) initiative

AD Dick, JT Rosenbaum, HA Al-Dhibi, R Belfort Jr… - Ophthalmology, 2018 - Elsevier
Topic An international, expert-led consensus initiative to develop systematic, evidence-
based recommendations for the treatment of noninfectious uveitis in the era of biologics …

Pathogenesis and current therapies for non-infectious uveitis

X Wu, M Tao, L Zhu, T Zhang, M Zhang - Clinical and Experimental …, 2023 - Springer
Non-infectious uveitis (NIU) is a disorder with various etiologies and is characterized by eye
inflammation, mainly affecting people of working age. An accurate diagnosis of NIU is crucial …

Advancements in the management of uveitis

S Schwartzman - Best practice & research Clinical rheumatology, 2016 - Elsevier
Uveitis may exist as a clinical manifestation of an underlying systemic disease or may
represent an idiopathic entity, sometimes with a very characteristic pattern. Different forms of …

Characteristics of Behcet's disease in the American Southwest

M Muruganandam, NA Rolle, WL Sibbitt Jr… - Seminars in Arthritis and …, 2019 - Elsevier
Objective The goal of this study was to determine the characteristics of Behçet's disease
(BD) in the American Southwest. Material and methods This was a cross-sectional study of …

Recent advances in the management of non-infectious posterior uveitis

RB Singh, S Sinha, C Saini, E Elbasiony… - International …, 2020 - Springer
Purpose To review the current regimens and novel therapeutic modalities in various stages
of research and development for the management of non-infectious posterior uveitis (NIPU) …

Recommendations statement on the immunosuppressive treatment of non-infectious, non-neoplastic, non-anterior uveitis

G Espinosa, JM Herreras, S Muñoz-Fernández… - … Clínica (English Edition), 2020 - Elsevier
Objective To generate recommendations on the use of immunomodulators in patients with
non-infectious, non-neoplastic intermediate uveitis (IU), posterior uveitis (PU) and panuveitis …

Documento de recomendaciones sobre el tratamiento con inmunodepresores de la uveítis no anterior, no infecciosa, no neoplásica

G Espinosa, JM Herreras, S Muñoz-Fernández… - Medicina Clínica, 2020 - Elsevier
Objetivo Desarrollar recomendaciones basadas en la mejor evidencia disponible y
experiencia sobre el uso de inmunomoduladores en pacientes con uveítis, las uveítis …

Clinical and Demographic Characteristics of Uveitis Patients: Eastern Black Sea Region Sample

N Gürsoy, N Akyol, A Türk - Kafkas Journal of Medical Sciences, 2024 - dergipark.org.tr
Aim: Uveitis is one of the leading causes of visual impairment worldwide. This study aims to
delineate the demographic and clinical characteristics of uveitis patients who underwent …

Immunomodulatory therapy of autoimmune diseases: Quo vadis?

BF Hoyer, F Hiepe - Der Ophthalmologe, 2016 - Springer
Zusammenfassung Immunmodulatorische Therapien sind der Goldstandard in der
Behandlung von Autoimmunerkrankungen. Ein immer besseres Verständnis der …

[引用][C] НІКОЛАЄНКО МАРИНА МИКОЛАЇВНА

О ПРОТИЗАПАЛЬНИХ, Ц УВЕЇТАХ, УУЗ НЕРВА